Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine...
Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental...
Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...
MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...
Mitesco (MITI) Announces Fourth Minneapolis and First Denver Lease for the Good Clinic.
Mitesco Announces Lease for Fourth Minneapolis Location and First Lease for the Good Clinic(TM) Operation in Denver
MINNEAPOLIS, MN,...
urban-gro (UGRO) We Have Another Double!
Last May we asked, "Is Urban-Gro the Most Undervalued Cannabis Play in the Market?" Looks like it was, having doubled less than...
OMNIQ (OMQS) to Begin Trading on NASDAQ
100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ.
Yes, some...
Huge News at Ehave Inc.(EHVVF), our Favorite Psychedelic.
We just finished compiling the 2021 Psychedelic Investor Guide and reviewed 44 companies - in all shapes and sizes. Excluding Johnson &...
Alkaline Water Co., (WTER) Announces 33rd Straight Up Quarter.
"This quarter also saw record revenue and strong continued growth. Even when compared to last year’s pantry-loading, our first quarter fiscal 2022...
Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.
Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
Draganfly (DPRO) Shareholder Call Today, 4PM EST.
https://youtu.be/SwKfEfKi8rU
Shareholder update call today August 12, 2021 at 2PM MST / 4PM EST.
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
